Endosialin presents an exciting target due to its strong upregulation on pericytes and CAFs in the tumor stroma, its lack of expression on pericytes associated with normal tissue vasculature and the absence of phenotype associated with the Cd248KO mouse. This evidence concerns the gene CD248 and neoplasm.